Veracyte, Inc. (VCYT) Q2 2014 Earnings Results

Veracyte Inc Misses on Revenue, Stock Down 0.07%

Veracyte's earnings report shows a slight miss on revenue expectations, although they beat on EPS. The stock reacted minimally, down just 0.07%, indicating that investors may have anticipated the challenges mentioned by management. The lack of guidance could lead to uncertainty among investors moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.31	N/A	+8.01%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed cautious optimism about future growth opportunities. They emphasized their commitment to innovation and market expansion.

Management highlighted ongoing efforts to expand product offerings.

They acknowledged challenges in the current market environment.

Focus remains on long-term growth despite short-term hurdles.

Veracyte Inc Misses on Revenue, Stock Down 0.07%

Key numbers

Management commentary

Veracyte, Inc.

More earnings this week

Veracyte Inc Misses on Revenue, Stock Down 0.07%

Key numbers

Management commentary